Role of reactive oxygen species in the pathogenesis of diabetic nephropathy

Diabetes Research and Clinical Practice

Volumn 82, Issue SUPPL. 1, 2008, Pages

  Ha, Hunjoo ^a   Hwang, In A ^a   Park, Jong Hee ^a   Lee, Hi Bahl ^b  

^a Ewha Womans University   (South Korea)

^b Kim's Clinic   (South Korea)

Author keywords

Antioxidant; Diabetic nephropathy; Mitochondrial electron gradient; NADPH oxidase; Oxidative stress; Protein kinase C; Reactive oxygen species

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; GLUCOSE; IRBESARTAN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; UNCOUPLING PROTEIN 1;

ARTICLE; DIABETIC NEPHROPATHY; DISEASE COURSE; GLYCEMIC CONTROL; HYPERGLYCEMIA; MITOCHONDRION; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 55249118568     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.017     Document Type: Article

References (37)

1. Wild S., Sicree R., Roglic G., King H., and Green A. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diab. Care 27 (2004) 1047-1053
2. WHO website: www.who.int/entity/diabetes/actionnow/en/mapdiabprev.pdf.
3. US Renal Data System. Excerpts from the USRDS 2006 Annual Data Report. Am. J. Kidney Dis. 49 Suppl. 1 (2007) S1-S296
4. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al., American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research and Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108 (2003) 2154-2169
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
7. Rösen P., Nawroth P.P., King G., Möller W., Tritschler H.J., and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diab./Metab. Res. Rev. 17 (2001) 189-212
8. Ha H., and Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int. 58 Suppl. 77 (2000) S19-S25
9. Lee H.B., Yu M.R., Yang Y., Jiang Z., and Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 14 Suppl. 8 (2003) S241-S245
10. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., and Haneda M. Effect of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 14 Suppl. 8 (2003) S250-S253
11. Brezniceanu M.L., Liu F., Wei C.C., Tran S., Sachetelli S., Zhang S.L., et al. Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int. 71 (2007) 912-923
12. Ha H., Kim C., Son Y., Chung M.-H., and Kim K.H. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic. Biol. Med. 16 (1994) 271-274
13. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 347 (1996) 444-445
14. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368 (1995) 225-229
15. Nourooz-Zadeh J., Tajaddini-Sarmadi J., McCarthy S., Betteridge D.J., and Wolff S.P. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44 (1995) 1054-1058
16. Bellomo G., Maggi E., Poli M., Agosta F.G., Bollati P., and Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44 (1995) 60-66
17. Calabrese V., Mancuso C., Sapienza M., Puleo E., Calafato S., Cornelius C., et al. Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12 (2007) 299-306
18. Lee E.A., Seo J.Y., Jiang Z., Yu M.R., Kwon M.K., Ha H., et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 upregulation in mesangial cells and in diabetic kidney. Kidney Int. 67 (2005) 1762-1771
19. Prabhakar S., Starnes J., Shi S., Lonis B., and Tran R. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J. Am. Soc. Nephrol. 18 (2007) 2945-2952
20. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
21. Ha H., Yu M.R., Choi Y.J., Kitamura M., and Lee H.B. Role of high glucose-induced nuclear factor-kappa B activation in monocyte chemoattractant protein-1 expression by mesangial cells. J. Am. Soc. Nephrol. 13 (2002) 894-902
22. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizawa N., and Grindling K.K. p22Phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271 (1996) 23317-23321
23. Leehey D.J., Isreb M.A., Marcic S., Singh A.K., and Singh R. Effect of high glucose on superoxide in human mesangial cells: role of angiotensin II. Nephron Exp. Nephrol. 100 (2005) e46-e53
24. Onozato M.L., Tojo A., Goto A., Fujita T., and Wilcox C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 61 (2002) 186-194
25. Studer R.K., Craven P.A., and DeRubertis F.R. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46 (1997) 918-925
26. Ha H., Yu M.R., Choi Y.J., and Lee H.B. Activation of protein kinase C-δ and -ε by oxidative stress in early diabetic kidney. Am. J. Kidney Dis. 38 Suppl. 4 (2001) S204-S207
27. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M., and Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46 (1997) 847-853
28. Jiang Z., Seo J.Y., Ha H., Yu M.R., Kwon M.K., and Lee H.B. Reactive oxygen species mediated TGF-β1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells. Biochem. Biophys. Res. Commun. 309 (2003) 961-966
29. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.T., et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol. 16 (2006) 667-675
30. Ha H., Yu M.R., and Kim K.H. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic. Biol. Med. 26 (1999) 944-950
31. Iglesias-De La Cruz M.C., Ruiz-Torres P., Alcami J., Diez-Marques L., Ortega-Velazquez R., Chen S., et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int. (2001) 87-95
32. Hsieh T.J., Fustier P., Wei C.C., Zhang S.L., Filep J.P., Tang S.S., et al. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J. Endocrinol. 183 (2004) 535-550
33. Lewis E.J., Hunsicker L.G., Bain R.P., and Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collabrative Study Group. N. Engl. J. Med. 329 (1993) 1456-1462
34. Lewis E.J., Hunsicker L.G., Clarke W.R., Berl T., Pohl M.A., Lewis J.B., et al., Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345 (2001) 851-860
35. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50 (2001) 2114-2125
36. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengellér Z., Szabó C., et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112 (2003) 1049-1057
37. Hamada Y., Miyata S., Nii-Kono T., Kitazawa R., Kitazawa S., Higo S., et al. Overexpression of thioredoxin 1 in transgenic mice suppresses development of diabetic nephropathy. Nephrol. Dial. Transplant. 22 (2007) 1547-1557